<SEC-DOCUMENT>0000000000-23-007961.txt : 20231215
<SEC-HEADER>0000000000-23-007961.hdr.sgml : 20231215
<ACCEPTANCE-DATETIME>20230725183005
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000000000-23-007961
CONFORMED SUBMISSION TYPE:	UPLOAD
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230725

FILED FOR:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHINA PHARMA HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001106644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				731564807
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		UPLOAD

	BUSINESS ADDRESS:	
		STREET 1:		2ND FLOOR, NO. 17, JINPAN ROAD
		STREET 2:		HAIKOU
		CITY:			HAINAN PROVINCE
		STATE:			F4
		ZIP:			570216
		BUSINESS PHONE:		8689866811730

	MAIL ADDRESS:	
		STREET 1:		2ND FLOOR, NO. 17, JINPAN ROAD
		STREET 2:		HAIKOU
		CITY:			HAINAN PROVINCE
		STATE:			F4
		ZIP:			570216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TS ELECTRONICS INC
		DATE OF NAME CHANGE:	20030818

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SOFTSTONE INC
		DATE OF NAME CHANGE:	20030128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SOFTSTONE INC /DE/
		DATE OF NAME CHANGE:	20010808
PUBLIC REFERENCE ACCESSION NUMBER:		0001213900-23-024710
</SEC-HEADER>
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.pdf
<TEXT>
<PDF>
begin 644 filename1
M)5!$1BTQ+C4*)>+CS],*,2 P(&]B:@H\/"]#;VQO<E-P86-E+T1E=FEC94=R
M87DO4W5B='EP92]);6%G92](96EG:'0@,C0W+T9I;'1E<B]&;&%T941E8V]D
M92]4>7!E+UA/8FIE8W0O5VED=&@@,30R."],96YG=&@@,S8U+T)I='-097)#
M;VUP;VYE;G0@.#X^<W1R96%M"GB<[<&!     ,,@?^K=X 15 0
M
M
M
M
M
M
M
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M"U83J5T@@&P1%G"3H7!4FZX<NV,R$6PM:#;"!>>"GG!Q%%,ZAPK16+#E0+[
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MK:3?LM9=:]I%7O<^\N1EVL52)E3-B5RI732RP&YZQ7L;E9L\(;>$JFY"4DQ
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M[DJ(3BP \P1YT[%F@K@_ABI=CEE6:YUI+I*V?YA>X&ASX6TA(B(B(B(B\M>
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M1$1$KB?C-C1+]9I!-8GU^)I9PNOK:]9018]8[/]M"D8T[_[^OMJ3/#T]I?Y
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M2"6M9RS,,2T@#VF6G&@7I$\=I@Y95F)U(HP0&H*#LJ6&_5PZ[6(I\D54>'^
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M/,)>C85 M;04E&,M<$_MM@ <ABERF/RN(*FH4H\D-^XL8>I&OCY9[HIB0.Y
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M^T O?$@#2+&,LWH@\?1 QB$RR @Y?4*:L85O?4\/4A]ADKSS^B (!GEK&R.
M"]LH^]^71]YW>X.T?"]V,Q^2-'*S47)-R1H0LN%ZS64CE 2EH5"RT:J"FRTT
M)8?+KV>P5&NN98T8*)DA4,VV^+CF@#9;U6JX:8V0W-#F,*<]>>*YD<T,\>1U
MS:H6C1>=L>%%JT4CN'%A]R<'S6LAY[0'%*(#JU:;EB%]HV#!YURS:F $NJVX
M<4[Q1HEE)4K,LH9O?79W<#T5LJA:JA?LM\W]/M9\Z=P]+/D<]< 7#,/ZUDJ,
MX!1;Z+L=7Z'J&C/=2[D137EW_09JSB1R$-U*&8-RH>8.S(7F14.R8M;VV2%I
M.MB&:\KZ'G.*%T=PT/&RUG!KV.%M23M/-9/85+:&E,1*5:(@[7";P8IK0Y%L
M2HY8)"RU:I<E&9[BP\'=]:G:2+0LQ8K<K%5#8C[4Q:$>LAHPFY(&1=XWPG#W
MAU<U]__W_G!.Q)DW.DJ[P>>X@VT%L"GL1"7Y16,.*J+)Q*R4-.*FXK!0VIJP
M K5DQ78T)N(D[AN-?+$YOVT1U%=::"R^*2IE6DTUD*JA_C,-8JD^%(+F:\$W
M#H5$_(ABQ?[\LQO#94&'<\P:^WV;]>!^0J#GQ<)]IIY#_?!>A#A,NXDPT/ %
M+C":(.PT>*0(?Z'T-*6H_S!>F*&.@L-GIG%.:0>N*&KXJ2A4BP#9.#LLT_44
MAS(>5$SU;9A&T0[U^!6UDO 'P_,@G;$D>#MWDO2.2.!WFLFB!+P9^ *%'7F-
M\F@G[-SK!NAMRPVIB5.,+YFV)=J7!;II.2)%#_WQ6^#=(PM!P[!A#>]LJ"4T
MKW ]1P$:G&O&W>TN*\X,OU?CO:@J=/Z1+45K[L5H&J4EWPZE&'-G^T%.R:1Y
MDI)$%PJ%+<Z8Q!'R";.HGM8@"9)@1SUI>]'.A <97MI(49(<]4'OX@@:QT=7
MX$%^%A3Y?8;?'TB8^&09I$>17.$EP[$:6^>E:?FAZ\6O/B!=1&&.[3EV\EZL
MA>DOAC.E5THS>YK/;3/Q8^UZ7_A?.AVY^GVQ$'92X/^C!8<K/&#HP?S'H_U?
MW2=,9@IE;F1S=')E86T*96YD;V)J"C$U(# @;V)J"CP\+U1Y<&4O0V%T86QO
M9R]086=E<R V(# @4CX^"F5N9&]B:@HQ-B P(&]B:@H\/"]-;V1$871E*$0Z
M,C R,S W,C4Q-S0X-3$M,#0G,# G*2]#<F5A=&]R*&UC8V%N;FHI+T-R96%T
M:6]N1&%T92A$.C(P,C,P-S(U,3<T.#4Q+3 T)S P)RDO4')O9'5C97(H:51E
M>'2N(#4N-"XU(*DR,# P+3(P,3,@,50S6%0@0E9"02!<*$%'4$PM=F5R<VEO
M;EPI*2]!=71H;W(H;6-C86YN:BDO5&ET;&4H0TA)3D$@4$A!4DU!($A/3$1)
M3D=3+"!)3D,N(#$P+4L@3&5T=&5R+G!D9BD^/@IE;F1O8FH*." P(&]B:@H\
M/"]&:6QT97(O1FQA=&5$96-O9&4O5'EP92]/8FI3=&TO3&5N9W1H(#(T-B]&
M:7)S=" T,R].(#<^/G-T<F5A;0IXG+52VVK#, S]%?W <&PG30LET)3U9926
MK+!!Z8.;B."RV*-.8/O['2>,L:==H& A"1V=(POEE)#$2V&*E,X1DM89:4HU
MC+)D3C/*YHJ62['VKF?7!\K05HG#^RN+O6E95!S\<*TY +0!*#H)CHC:*- @
M* KQO#M?N(Y5V[62U%A'"/$) <S>7"$!S5C;<F--Z=^."=(9)LP7ZE04WV99
M_'Z6_PE(>7,%?2.%Q^'<1]+(+"?^2"=*$W@,#K;C<%?YSCAQ[VK?6->*)^M6
M+MC/_$]4I7]I?F!ZL$TXYG'T>'JC4Y,;[^3TM8> %0WX9XK&#VNOQP\*96YD
M<W1R96%M"F5N9&]B:@HQ-R P(&]B:@H\/"]);F9O(#$V(# @4B]&:6QT97(O
M1FQA=&5$96-O9&4O5'EP92]84F5F+U=;,2 R(#)=+TEN9&5X6S @,3A=+TE$
M(%L\,#0Q8SAE83,Y-#8Y8C@V-S4X8S0V-S4S8S$P,F$T8V8^/# T,6,X96$S
M.30V.6(X-C<U.&,T-C<U,V,Q,#)A-&-F/ETO4F]O=" Q-2 P(%(O3&5N9W1H
M(#<Q+U-I>F4@,3@^/G-T<F5A;0IXG&-@8/C_GY&!GX&!D4F2@8&)@8.!!42P
M,J8<@G#90 0#8V,+D,AFAH@Q,A;;0UA,C-50=<R,#1E )0W3&$#@_W\ ILT+
M$0IE;F1S=')E86T*96YD;V)J"B5I5&5X="TU+C0N-0IS=&%R='AR968*,S,T
).30*)25%3T8*

end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
United States securities and exchange commission logo





                             July 25, 2023

       Zhilin Li
       Interim Chief Financial Officer
       China Pharma Holdings, Inc.
       Second Floor, No. 17, Jinpan Road
       Haikou, Hainan Province, China, 570216

                                                        Re: China Pharma
Holdings, Inc.
                                                            Form 10-K for
Fiscal Year Ended December 31, 2022
                                                            Filed March 30,
2023
                                                            File No. 001-34471

       Dear Zhilin Li:

              We have reviewed your filing and have the following comments. In
some of our
       comments, we may ask you to provide us with information so we may better
understand your
       disclosure.

              Please respond to these comments within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comments apply to your facts and circumstances, please tell us why in
your response.

                                                        After reviewing your
response to these comments, we may have additional comments.

       Form 10-K for Fiscal Year Ended December 31, 2022

       Part I
       Item 1. Business, page 1

   1.                                                   At the onset of Part I,
please disclose prominently that you are not a Chinese operating
                                                        company but a Nevada
holding company with operations conducted by your subsidiaries.
   2.                                                   Provide prominent
disclosure about the legal and operational risks associated with being
                                                        based in or having the
majority of the company   s operations in China. Your disclosure
                                                        should make clear
whether these risks could result in a material change in your operations
                                                        and/or the value of
your securities or could significantly limit or completely hinder your
                                                        ability to offer or
continue to offer securities to investors and cause the value of such
                                                        securities to
significantly decline or be worthless. Your disclosure should address how
                                                        recent statements and
regulatory actions by China   s government, such as those related to
                                                        data security or
anti-monopoly concerns, have or may impact the company   s ability to
 Zhilin Li
FirstName  LastNameZhilin
China Pharma  Holdings, Inc.Li
Comapany
July       NameChina Pharma Holdings, Inc.
     25, 2023
July 25,
Page  2 2023 Page 2
FirstName LastName
         conduct its business, accept foreign investments, or list on a U.S. or
other foreign
         exchange.
3.       Please prominently disclose whether your auditor is subject to the
determinations
         announced by the PCAOB on December 16, 2021 and whether and how the
Holding
         Foreign Companies Accountable Act, as amended by the Consolidated
Appropriations
         Act, 2023, and related regulations will affect your company.
4.       Clearly disclose how you will refer to the holding company and
subsidiaries when
         providing the disclosure throughout the document so that it is clear
to investors which
         entity the disclosure is referencing and which subsidiaries or
entities are conducting the
         business operations. For example, disclose, if true, that your
subsidiary conducts
         operations in China.
5.       Provide a clear description of how cash is transferred through your
organization. Disclose
         your intentions to distribute earnings. Quantify any cash flows and
transfers of other
         assets by type that have occurred between the holding company and its
subsidiaries, and
         direction of transfer. Quantify any dividends or distributions that
subsidiaries have made
         to the holding company and which entity made such transfer, and their
tax consequences.
         Similarly quantify dividends or distributions made to U.S. investors,
the source, and their
         tax consequences. Your disclosure should make clear if no transfers,
dividends, or
         distributions have been made to date. Describe any restrictions on
foreign exchange and
         your ability to transfer cash between entities, across borders, and to
U.S.
         investors. Describe any restrictions and limitations on your ability
to distribute earnings
         from the company, including your subsidiaries, to the parent company
and U.S. investors.
6.       Disclose each permission or approval that you or your subsidiaries are
required to obtain
         from Chinese authorities to operate your business and to offer
securities to foreign
         investors. State whether you or your subsidiaries are covered by
permissions
         requirements from the China Securities Regulatory Commission (CSRC),
Cyberspace
         Administration of China (CAC) or any other governmental agency that is
required to
         approve your operations, and state affirmatively whether you have
received all requisite
         permissions or approvals and whether any permissions or approvals have
been denied.
         Please also describe the consequences to you and your investors if you
or your
         subsidiaries: (i) do not receive or maintain such permissions or
approvals, (ii)
         inadvertently conclude that such permissions or approvals are not
required, or (iii)
         applicable laws, regulations, or interpretations change and you are
required to obtain such
         permissions or approvals in the future.
Management's Discussion and Analysis of Financial Condition and Results of
Operations, page
46

7.       Please address the following regarding your accounts receivable and
related allowance for
         doubtful accounts:

                Tell us and revise to clearly state your write-off policy.
Identify the point in time at
 Zhilin Li
FirstName  LastNameZhilin
China Pharma  Holdings, Inc.Li
Comapany
July       NameChina Pharma Holdings, Inc.
     25, 2023
July 25,
Page  3 2023 Page 3
FirstName LastName
              which you write off a receivable, including the extent to which
write-offs are made
              on a specific versus general basis.
                To the extent you do conduct write-offs of uncollectible
accounts receivables, explain
              why write-offs are not separately quantified in your roll forward
of the allowance at
              the top of page 50.
                You provide an aging distribution breakdown at the bottom of
page 50 for four
              different aging segments of your receivable portfolio by
percentage. Revise to
              provide a similar aging distribution both for your gross accounts
receivables as well
              as your allocated allowance for doubtful accounts in dollars.
                You disclose on page 50 that deferred payments to
pharmaceutical companies by
              state-owned hospitals and local medicine distributors are common.
Revise to discuss
              the relative collectability of receivables separately from each
of these customer
              classes and to discuss the extent to which your allowance
methodology differentiates
              between these customers. Identify any other significant customer
classes.
                To the extent state-owned hospitals reflect a different
collectability pattern from local
              medicine distributors, consider breaking out your aging
distribution between these
              two customer types, and provide a breakdown of revenue by
customer class.
                To the extent you do not receive payments on receivables from
state-owned hospitals,
              discuss the way you determine such payments are omitted due to
credit quality issues
              versus other reasons such as pricing discounts, contractual
adjustments, or other
              allowance adjustments to revenue.
                Tell us the reasons for the fluctuations in your allowance as a
percentage of accounts
              receivable and the reasons for the changes in your negative bad
debt expense for the
              periods presented. Revise accordingly to more clearly address
such fluctuations.
General

8.       Prominently disclose the risks that your corporate structure and being
based in or having
         the majority of the company   s operations in China poses to
investors. In particular,
         describe the significant regulatory, liquidity, and enforcement risks.
For example,
         specifically discuss risks arising from the legal system in China,
including risks and
         uncertainties regarding the enforcement of laws and that rules and
regulations in China
         can change quickly with little advance notice; and the risk that the
Chinese government
         may intervene or influence your operations at any time, or may exert
more control over
         offerings conducted overseas and/or foreign investment in China-based
issuers, which
         could result in a material change in your operations and/or the value
of your securities.
         Acknowledge any risks that any actions by the Chinese government to
exert more
         oversight and control over offerings that are conducted overseas
and/or foreign investment
         in China-based issuers could significantly limit or completely hinder
your ability to offer
         or continue to offer securities to investors and cause the value of
your securities to
         significantly decline or be worthless
9.       Given the significant oversight and discretion of the government of
the People   s Republic
         of China (PRC) over the operations of your business, please describe
any material impact
 Zhilin Li
China Pharma Holdings, Inc.
July 25, 2023
Page 4
         that intervention or control by the PRC government has or may have on
your business or
         on the value of your securities. We remind you that, pursuant to
federal securities rules,
         the term    control    (including the terms    controlling,
controlled by,    and    under
         common control with   ) means    the possession, direct or indirect,
of the power to direct or
         cause the direction of the management and policies of a person,
whether through the
         ownership of voting securities, by contract, or otherwise."
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

        You may contact Tracie Mariner, Staff Accountant, at (202) 551-3744 or
Kevin Vaughn,
Accounting Branch Chief, at (202) 551-3494 if you have questions regarding
comments on the
financial statements and related matters. Please contact Dillon Hagius, Staff
Attorney, at (202)
551-7967 or Joe McCann, Legal Branch Chief, at (202) 551-6262 with any other
questions.



FirstName LastNameZhilin Li                                   Sincerely,
Comapany NameChina Pharma Holdings, Inc.
                                                              Division of
Corporation Finance
July 25, 2023 Page 4                                          Office of Life
Sciences
FirstName LastName
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
